SMAD3 and pulmonary arterial hypertension: The TGF-β1/Smad2/Smad3 pathway plays an important role in cardiovascular fibrosis, and imbalance between TGF-β signaling and BMPRII signaling have been proven to contribute to PAH pathogenesis (27, 28).